About one third of people with continuous positive airway pressure (CPAP) devices and masks treat sleep apnoea are not obesity related.
In a study, Obstructive Sleep Apnoea without Obesity Is Common and Difficult to Treat: Evidence for a Distinct Pathophysiological Phenotype, has the following results in 2017: Twenty-five percent of the participants with a diagnosis of OSA (obstructive sleep apnea) had a body mass index (BMI) within the normal range (BMI < 25 kg/m2) and 54% had a BMI < 30 kg/m2 (nonobese).
Buy RMD now and get great upside returns in a year or two, page-33
-
- There are more pages in this discussion • 174 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$36.88 |
Change
-0.720(1.91%) |
Mkt cap ! $23.36B | |||
| Open | High | Low | Value | Volume |
| $37.36 | $37.42 | $36.84 | $54.23M | 1.466M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 11087 | $36.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $36.90 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| RMD (ASX) Chart |